Cargando…
Clofazimine: A potential therapeutic option for severe COVID-19
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880843/ https://www.ncbi.nlm.nih.gov/pubmed/33735762 http://dx.doi.org/10.1016/j.mehy.2021.110535 |
| _version_ | 1783650762177380352 |
|---|---|
| author | Ateya, Areej Mohamed |
| author_facet | Ateya, Areej Mohamed |
| author_sort | Ateya, Areej Mohamed |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7880843 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78808432021-02-16 Clofazimine: A potential therapeutic option for severe COVID-19 Ateya, Areej Mohamed Med Hypotheses Letter to Editors Published by Elsevier Ltd. 2021-05 2021-02-13 /pmc/articles/PMC7880843/ /pubmed/33735762 http://dx.doi.org/10.1016/j.mehy.2021.110535 Text en © 2021 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to Editors Ateya, Areej Mohamed Clofazimine: A potential therapeutic option for severe COVID-19 |
| title | Clofazimine: A potential therapeutic option for severe COVID-19 |
| title_full | Clofazimine: A potential therapeutic option for severe COVID-19 |
| title_fullStr | Clofazimine: A potential therapeutic option for severe COVID-19 |
| title_full_unstemmed | Clofazimine: A potential therapeutic option for severe COVID-19 |
| title_short | Clofazimine: A potential therapeutic option for severe COVID-19 |
| title_sort | clofazimine: a potential therapeutic option for severe covid-19 |
| topic | Letter to Editors |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880843/ https://www.ncbi.nlm.nih.gov/pubmed/33735762 http://dx.doi.org/10.1016/j.mehy.2021.110535 |
| work_keys_str_mv | AT ateyaareejmohamed clofazimineapotentialtherapeuticoptionforseverecovid19 |